|
MMP-1
|
COLI
|
Regulated to facilitate melanoma cell growth and invasion
|
[227, 228]
|
|
COLIV
|
Regulated to foster breast cancer cell invasion in response to prolactin
|
[229]
|
|
MMP-2
|
COLI
|
Modulating MMP-2 activation in osteosarcoma
|
[230]
|
|
COL4A2
|
Modulating MMP-2 activation and activity in liver cancer
|
[231]
|
|
COLI and COLIV
|
Regulated by the knockdown of MMP-2 to induce cancer metastases
|
[232, 233]
|
|
Collagen organization
|
Regulated to enhance malignant glioma recurrence and resistance to vemurafenib
|
[234, 235]
|
|
MMP-3
|
COLI
|
Regulated to induce mammary epithelial cells invasion and morphogenesis with chaperone heat-shock protein 90
|
[236]
|
|
COL11A1
|
Regulated to promote ovarian cancer progression
|
[237]
|
|
MMP-7
|
COLI
|
Both to predict the prognosis of opisthorchiasis-associated cholangiocarcinoma
|
[238]
|
|
MMP-9
|
COLI
|
Degraded in invasive melanoma fronts
|
[239]
|
| |
COLI
|
Potentiated in Opisthorchis viverrini-induced cholangiocarcinogenesis
|
[240]
|
|
COLIV
|
Degraded to facilitate venous invasion in PDAC
|
[241]
|
|
MMP-10
|
COLI
|
Regulated by TGF-β in keratinocytes to promote invasion
|
[242]
|
|
MMP-14
|
COLI
|
Increased to promote fibrosis by TGF-β signaling in PDAC
|
[243]
|
|
COLI
|
Modulating MMP-2 and MMP-14 activation via β1 integrin
|
[244]
|
|
COLI
|
Regulated to prevent apoptosis to promote luminal-like breast cancer progression
|
[245]
|
|
COLI
|
Sustained activation of MMP-14 with EGFR at the cell surface enhances invasion, whereas growth within three-dimensional collagen is inhibited
|
[246]
|
|
MMP-16
|
COLI
|
Supported around melanoma cells to enhance lymphatic invasion
|
[247]
|
|
MMP-28
|
COLII
|
interacted to more adhesion and less migratory
|
[248]
|
